CytomX Therapeutics (CTMX) Interest Expenses (2014 - 2017)
CytomX Therapeutics (CTMX) reported Interest Expenses of $206000.0 for Q1 2017, down 41.64% on a YoY basis from $353000.0 in Q1 2016, and down 47.04% quarter-over-quarter from $389000.0 in Q4 2016.
CytomX Therapeutics (CTMX) Interest Expenses (2014 - 2017) Analysis & Trends
CytomX Therapeutics has reported Interest Expenses for 4 years, with the latest figure at $206000.0 in Q1 2017.
- For the quarter ending Q1 2017, Interest Expenses fell 41.64% year-over-year to $206000.0; the trailing twelve-month figure through Dec 2017 stood at $206000.0 (down 87.8% YoY), and the FY2016 full-year result was $1.7 million, down 2.48% from the prior year.
- Interest Expenses for Q1 2017 stood at $206000.0, down from $389000.0 in the prior quarter.
- The five-year high for Interest Expenses was $718000.0 in Q3 2015, with the low at $109000.0 in Q4 2014.
- Historically, Interest Expenses has averaged $350272.7 across 4 years, with a median of $376000.0 in 2015.
- Annual changes were most pronounced in 2015 — Interest Expenses surged 513.68% — and 2017, when it sank 41.64%.
- CytomX Therapeutics' Interest Expenses stood at $109000.0 in 2014, then jumped by 244.95% to $376000.0 in 2015, then gained by 3.46% to $389000.0 in 2016, then sank by 47.04% to $206000.0 in 2017.
- The last three Interest Expenses figures came in at $206000.0 (Q1 2017), $389000.0 (Q4 2016), and $482000.0 (Q3 2016), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | CytomX Therapeutics | 520.30 Mn | 173.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 206,000.00 |
| Mar 31, 2017 | 206,000.00 |
| Dec 31, 2016 | 389,000.00 |
| Dec 31, 2016 | 389,000.00 |
| Sep 30, 2016 | 482,000.00 |
| Sep 30, 2016 | 482,000.00 |
| Jun 30, 2016 | 465,000.00 |
| Jun 30, 2016 | 465,000.00 |
| Mar 31, 2016 | 353,000.00 |
| Mar 31, 2016 | 353,000.00 |
| Dec 31, 2015 | 376,000.00 |
| Dec 31, 2015 | 376,000.00 |
| Sep 30, 2015 | 718,000.00 |
| Sep 30, 2015 | 718,000.00 |
| Jun 30, 2015 | 408,000.00 |
| Jun 30, 2015 | 408,000.00 |
| Mar 31, 2015 | 230,000.00 |
| Mar 31, 2015 | 230,000.00 |
| Dec 31, 2014 | 109,000.00 |
| Dec 31, 2014 | 109,000.00 |